openPR Logo
Press release

Worldwide Analysis on Pericaditis Market 2020 Focus on Top Leaders -Novartis International AG, Pfizer Inc., AstraZeneca Plc., PerkinElmer, Sanofi, Johnson & Johnson Services, Reckitt Benckiser Group Plc, FUJIFILM Holdings Corporation, Bayer AG, Merck & Co

12-14-2020 03:32 PM CET | Health & Medicine

Press release from: Market Research Future

Worldwide Analysis on Pericaditis Market 2020 Focus on Top

Pericarditis Market Overview:

“Pericaditis Market: By Type (Acute Pericarditis, Chronic Pericarditis and Recurrent Pericarditis), By Diagnosis and Treatment [Diagnosis (Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (CT), and X-Ray), Treatment (Medication and Surgical Treatment)], By End User (Hospitals and Clinics, Medical Institutes, Research Organizations and Others) and By Region - Global Forecast Till 2023”

(Download Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7212)

According to Market Research Future (MRFR)’s analysis, the global pericarditis market is expected to touch a valuation of USD 2,741.39 Mn by the end of 2023 up from USD 1,750.38 Mn in 2017. The report also reveals that the market is predicted to thrive at a CAGR of 7.96% during the forecast period 2018 to 2023. Cardiovascular diseases are widely prevalent across the world, and the patient population is presumed to increase further over the next couple of years. A major proportion of these patients are likely to develop symptoms of pericarditis. It has been projected that the pericarditis market will witness an influx of patient population, thus, generating demand for advanced drugs and treatments.

The advent of advanced minimally invasive surgeries has revolutionized the pericarditis market. It has encouraged patients for early diagnosis and treatment. Also, the introduction of robot-assisted cardiac surgeries has gained considerable popularity among the patients due to its assurance of precision. This, in turn, is likely to have a positive influence on the proliferation of the pericarditis market.

The trouble-free settlement of reimbursements is anticipated to favor the growth of the market through the assessment period. On the flip side, the risk of infections owing to the insertion of catheters in the body remains an impediment to the market growth. Furthermore, the continuous dosages of anti-inflammatory drugs used for the treatment of pericarditis can lead to side-effects. It is predicted to hinder the expansion of the pericarditis market in the foreseeable future.

Global Market for Pericarditis – Segmental Analysis:

This MRFR report offers a comprehensive segmental assessment of the global pericarditis market based on type, diagnosis & treatment, and end-user. By type, the market is segmented into acute pericarditis, chronic pericarditis, and recurrent pericarditis. Among these, the acute pericarditis market is presumed to account for a major share of the market in the upcoming years. The valuation of the segment is forecasted to grow from USD 888.91 Mn in 2017 to USD 1,365.94 Mn in 2023. Meanwhile, the recurrent pericarditis segment is expected to expand at a comparatively higher CAGR during the projection period.

By diagnosis & treatment, the pericarditis market has been segmented into diagnosis and treatment. The diagnosis segment has been further sub-segmented into electrocardiogram, echocardiogram, CT, X-ray, and others. The treatment segment is sub-segmented into medication, surgical treatment, and others. Among these, the treatment segment is projected to attract a larger customer base across the review period. However, the diagnosis segment is anticipated to strike a relatively higher CAGR of 8.32% over 2023.

By end-user, the global pericarditis market has been segmented into hospitals and clinics, medical institutes & research organizations, and others. Among these, the hospitals and clinics segment has been estimated to expand at a CAGR of 8.05% over the assessment period. Its valuation is expected to reach USD 1,323.16 Mn over 2023.

Regional Outlook:

The global pericarditis market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas is the largest regional market for pericarditis and is poised to touch a valuation of USD 1,122.46 Mn towards the end of 2023. The drastic increase in the healthcare expenditure of the U.S. and Canada is contributing significantly towards the development of the pericarditis market in the region.

Europe, on the second spot, has been expected to strike a relatively higher CAGR of 9.14% during the forecast period. The access to affordable and standard medical facilities in the region is poised to boost the future trajectory of the pericarditis market. In addition, the efforts directed towards the development of the health systems in the region is further anticipated to propel the expansion of the market.

Global Market for Pericarditis – Competitive Dashboard:

Some of the prominent players operating in the global pericarditis market are Pfizer Inc., Bayer AG, AstraZeneca Plc., Reckitt Benckiser Group Plc, Novartis International AG, PerkinElmer, Inc., FUJIFILM Holdings Corporation, Merck & Co., Inc., Sanofi, Allergan plc., and Johnson & Johnson Services, Inc.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/pericaditis-market-7212

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Worldwide Analysis on Pericaditis Market 2020 Focus on Top Leaders -Novartis International AG, Pfizer Inc., AstraZeneca Plc., PerkinElmer, Sanofi, Johnson & Johnson Services, Reckitt Benckiser Group Plc, FUJIFILM Holdings Corporation, Bayer AG, Merck & Co here

News-ID: 2209401 • Views:

More Releases from Market Research Future

Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by Segmentation, Competitors Analysis
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further. APAC Wallpaper Market Size was valued at USD 0.55

All 5 Releases


More Releases for Pericarditis

Pericarditis Treatment Market Overview, High Growth Opportunities, Segmentation, …
Global pericarditis treatment market is likely to be worth US$ 3.60 Billion in 2022, and is anticipated to grow at a CAGR of 5.24% during the projected period, reaching US$ 6 Billion by 2032. Pericarditis is a cardiovascular disease which represents the swelling of the pericardium wall of the heart. The main cause of pericardium disease is the inflammation of pericardium wall which is generally caused by viral infection. Other
Pericarditis Drugs Market Size to Expand Significantly by the End of 2027
Pericarditis Drugs Market Introduction Pericarditis is the inflammation of the pericardium. Pericardium is two thin layers of a sac like structure of tissues that surrounds the heart. The pericardium holds the heart in place and helps it work. It is a small amount of fluid that keeps both the layers separated from each other so that there is no friction between the layers. Pericarditis often causes chest pain and other symptoms
Pericarditis Treatment Market Key Manufacturers Analysis 2019 Industry Size by T …
Pericarditis is a cardiovascular disease which represents the swelling of the pericardium wall of the heart. The main cause of pericardium disease is the inflammation of pericardium wall which is generally caused by viral infection. Other causes of pericarditis disease are renal failure, bacterial infections and intake of some drugs such as procainamide. Pericarditis Treatment Industry Scrutinized The increasing prevalence of cardiovascular diseases such as heart attack & hypertension, favorable reimbursement
Pericarditis Drugs Market Scope, Demand, Supply and Key Manufacturers Analysis b …
“Pericarditis Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. Pericarditis is an inflammation of pericardium. It is the inflammation that occurs around the lining of the heart causing chest pain and accumulation of fluid around the pericardial effusion. There may
Pericarditis Drugs Market Overview and Regional Outlook Study 2018 – 2028
Global Pericarditis Drugs Market: Overview The demand within the global pericarditis drugs market has been rising on account of advancements in the field of cardiac treatments. The availability of pericarditis drugs is a positive sign for the pharmaceutical industry, and this factor has played a key role in market growth. There have been key advancements in the healthcare sector with regard to treatment and diagnosis of cardiovascular diseases. Pericarditis is
Pericarditis Market Size is set for Rapid Growth 2019 | Pfizer, Astrazeneca, Bay …
The Global Pericarditis market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Pericarditis Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Pericarditis market.